Correlation Between Pfizer and Rubis
Can any of the company-specific risk be diversified away by investing in both Pfizer and Rubis at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Rubis into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and Rubis, you can compare the effects of market volatilities on Pfizer and Rubis and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Rubis. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Rubis.
Diversification Opportunities for Pfizer and Rubis
Very poor diversification
The 3 months correlation between Pfizer and Rubis is 0.84. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Rubis in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rubis and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Rubis. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rubis has no effect on the direction of Pfizer i.e., Pfizer and Rubis go up and down completely randomly.
Pair Corralation between Pfizer and Rubis
If you would invest 2,500 in Rubis on September 5, 2024 and sell it today you would earn a total of 0.00 from holding Rubis or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 0.8% |
| Values | Daily Returns |
Pfizer Inc vs. Rubis
Performance |
| Timeline |
| Pfizer Inc |
| Rubis |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Pfizer and Rubis Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pfizer and Rubis
The main advantage of trading using opposite Pfizer and Rubis positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Rubis can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rubis will offset losses from the drop in Rubis' long position.| Pfizer vs. Crinetics Pharmaceuticals | Pfizer vs. Enanta Pharmaceuticals | Pfizer vs. Amicus Therapeutics | Pfizer vs. Connect Biopharma Holdings |
| Rubis vs. DCC PLC ADR | Rubis vs. Ultrapar Participacoes SA | Rubis vs. Sunoco LP | Rubis vs. HF Sinclair Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Complementary Tools
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |